SCHEMBL19106231

SCHEMBL19106231

c1ccc(-c2nc(-c3ccc(-c4nc(-c5cc6ccccc6c6ccccc56)c5ccccc5n4)cc3)nc3c2sc2ccccc23)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ ATM Q13315 1/20 0.45
▸ PDE5A O76074 3/20 0.36
▸ WHR1 P49842 1/20 0.35
▸ TNKS O95271 2/20 0.34
▸ TNKS2 Q9H2K2 2/20 0.34
▸ MAPT P10636 2/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ LMNA P02545 1/20 0.33
▸ RECQL P46063 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ PDK1 Q15118 1/20 0.33
▸ ABCG2 Q9UNQ0 3/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ NUDT1 P36639 1/20 0.33
▸ HCRTR1 O43613 1/20 0.32
▸ CYP1A1 P04798 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106319 0.97 ATM (0.41) MEN1KMT2AATMPDE5AWHR1
SCHEMBL19106505 0.92 KDM4E (0.39) MEN1KMT2AATMPDE5AWHR1
SCHEMBL19106205 0.90 MEN1 (0.39) MEN1KMT2AATMWHR1TNKS
SCHEMBL19106236 0.88 MEN1 (0.57) MEN1KMT2AATMPDE5AWHR1
SCHEMBL19106311 0.88 MEN1 (0.57) MEN1KMT2AATMPDE5AWHR1
SCHEMBL19106247 0.88 MEN1 (0.57) MEN1KMT2AATMPDE5AWHR1
SCHEMBL19106279 0.88 MEN1 (0.47) MEN1KMT2AATMPDE5AWHR1
SCHEMBL19106243 0.88 MEN1 (0.47) MEN1KMT2AATMPDE5AWHR1
SCHEMBL19106240 0.87 MEN1 (0.56) MEN1KMT2AATMPDE5AWHR1
SCHEMBL19106269 0.87 MEN1 (0.56) MEN1KMT2AATMPDE5AWHR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885ATM 2511/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885ATM 2511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback